PCN12 COST EFFECTIVENESS OF ERLOTINIB IN THE TREATMENT OF ADVANCED NON SMALL CELL LUNG CANCER (NSCLC) IN POLAND

Nov 1, 2006, 00:00 AM
10.1016/S1098-3015(10)63442-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)63442-0/fulltext
Section Title :
Section Order : 293
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)63442-0&doi=10.1016/S1098-3015(10)63442-0
HEOR Topics :
Tags :
Regions :